Company Filing History:
Years Active: 2025
Title: Todd Koretke: Innovator in Pharmaceutical Development
Introduction
Todd Koretke is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceutical development, particularly in the area of cancer treatment. His innovative work has led to the creation of a patent that addresses critical health issues.
Latest Patents
Todd Koretke holds a patent for "Substituted pyridines as DNMT1 inhibitors." This invention relates to substituted pyridine derivatives that inhibit the activity of DNA methyltransferase 1 (DNMT1). The patent also encompasses pharmaceutical compositions that include these compounds and outlines methods for using them in the treatment of cancer, pre-cancerous syndromes, beta haemoglobinopathy disorders, and other diseases associated with inappropriate DNMT1 activity. He has 1 patent to his name.
Career Highlights
Koretke is associated with GlaxoSmithKline Intellectual Property Development Limited, where he has been instrumental in advancing research and development initiatives. His work focuses on innovative solutions that address pressing medical challenges.
Collaborations
Throughout his career, Todd has collaborated with esteemed colleagues, including Andrew B Benowitz and David T Fosbenner. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Todd Koretke's contributions to pharmaceutical innovation exemplify the impact of dedicated inventors in the medical field. His work continues to pave the way for advancements in treatments for serious health conditions.